WallStSmart

The Cooper Companies, Inc (COO)vsMedline Inc. Class A Common Stock (MDLN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 607% more annual revenue ($29.94B vs $4.24B). COO leads profitability with a 13.5% profit margin vs 2.3%. COO trades at a lower P/E of 18.6x. COO earns a higher WallStSmart Score of 71/100 (B).

COO

Strong Buy

71

out of 100

Grade: B

Growth: 6.7Profit: 5.5Value: 8.0Quality: 6.5
Piotroski: 4/9Altman Z: 2.65

MDLN

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 4.0Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 1.70
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COOUndervalued (+60.4%)

Margin of Safety

+60.4%

Fair Value

$209.49

Current Price

$54.12

$155.37 discount

UndervaluedFair: $209.49Overvalued

Intrinsic value data unavailable for MDLN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COO4 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
357.1%10/10

Earnings expanding 357.1% YoY

PEG RatioValuation
0.528/10

Growing faster than its price suggests

Operating MarginProfitability
20.8%8/10

Strong operational efficiency at 20.8%

MDLN2 strengths · Avg: 9.0/10
EPS GrowthGrowth
262.0%10/10

Earnings expanding 262.0% YoY

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Areas to Watch

COO2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.6%4/10

0.6% revenue growth

Return on EquityProfitability
6.8%3/10

ROE of 6.8% — below average capital efficiency

MDLN4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.704/10

Distress zone — elevated risk

Return on EquityProfitability
6.0%3/10

ROE of 6.0% — below average capital efficiency

Profit MarginProfitability
2.3%3/10

2.3% margin — thin

Operating MarginProfitability
0.8%3/10

Operating margin of 0.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : COO

The strongest argument for COO centers on Price/Book, EPS Growth, PEG Ratio. PEG of 0.52 suggests the stock is reasonably priced for its growth.

Bull Case : MDLN

The strongest argument for MDLN centers on EPS Growth, Price/Book. Revenue growth of 11.6% demonstrates continued momentum.

Bear Case : COO

The primary concerns for COO are Revenue Growth, Return on Equity.

Bear Case : MDLN

The primary concerns for MDLN are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 42.6x leaves little room for execution misses. Thin 2.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

MDLN is growing revenue faster at 11.6% — sustainability is the question.

MDLN generates stronger free cash flow (604M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

COO scores higher overall (71/100 vs 52/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Cooper Companies, Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California.

Visit Website →

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Want to dig deeper into these stocks?